Janney Montgomery Scott
IBRX icon

Janney Montgomery Scott’s ImmunityBio IBRX Stock Holding History

Janney Montgomery Scott’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$628K Buy
71,696
+759
+1% +$5.75K ﹤0.01% 2242
2026
Q1 		$544K Buy
70,937
+47,006
+196% +$322K ﹤0.01% 1992
2025
Q4 		$47K Buy
+23,931
New +$54.2K ﹤0.01% 2891

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janney Montgomery Scott's IBRX Position: Q2 2026 in Review

Janney Montgomery Scott increased its ImmunityBio (IBRX) stake by 1.1% in Q2 2026, buying an estimated $5.75K and bringing the position to 71,696 shares worth $628K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Janney Montgomery Scott first reported a position in IBRX in Q4 2025 and has held it in 3 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Janney Montgomery Scott held 71,696 shares of ImmunityBio worth $628K as of Q2 2026.
  • Janney Montgomery Scott bought 759 ImmunityBio shares in Q2 2026, an estimated $5.75K.
  • ImmunityBio made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2242 holding.
  • Janney Montgomery Scott first reported a position in ImmunityBio in Q4 2025 and has held it in 3 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.